Report cover image

Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Publisher GlobalData
Published Nov 28, 2023
Length 118 Pages
SKU # GBDT18393327

Description

Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Artificial Pancreas under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Pancreas under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

118 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Artificial Pancreas Overview
4 Products under Development
4.1 Artificial Pancreas - Pipeline Products by Stage of Development
4.2 Artificial Pancreas - Pipeline Products by Territory
4.3 Artificial Pancreas - Pipeline Products by Regulatory Path
4.4 Artificial Pancreas - Pipeline Products by Estimated Approval Date
4.5 Artificial Pancreas - Ongoing Clinical Trials
5 Artificial Pancreas - Pipeline Products under Development by Companies
5.1 Artificial Pancreas Companies - Pipeline Products by Stage of Development
5.2 Artificial Pancreas - Companies Pipeline Products by Stage of Development
6 Artificial Pancreas Companies and Product Overview
6.1 Admetsys Corp Company Overview
6.1.1 Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
6.2 Advanced Biosensors-Ohio LLC Company Overview
6.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
6.3 AiTA Bio Inc Company Overview
6.3.1 AiTA Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 Beta Bionics Inc Company Overview
6.4.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Beta-O2 Technologies Ltd Company Overview
6.5.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.6 Bigfoot Biomedical Inc Company Overview
6.6.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 BioTex Inc Company Overview
6.7.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Captix Biomedical Pty Ltd Company Overview
6.8.1 Captix Biomedical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.9 Cerco Medical LLC Company Overview
6.9.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
6.1 Children's Hospital of Philadelphia Company Overview
6.10.1 Children's Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview
6.11 Converge Biotech, Inc. Company Overview
6.11.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.12 Covalor Medical, LLC Company Overview
6.12.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.13 De Montfort University Company Overview
6.13.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
6.14 Debiotech SA Company Overview
6.14.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
6.15 Defymed SAS Company Overview
6.15.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
6.16 Diabeloop SA Company Overview
6.16.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
6.17 EOFlow Co Ltd Company Overview
6.17.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.18 Giner Inc Company Overview
6.18.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
6.19 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview
6.19.1 Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
6.2 Healios Inc Company Overview
6.20.1 Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
6.21 Humacyte Inc Company Overview
6.21.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
6.22 Ideal Medical Technologies Inc Company Overview
6.22.1 Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.23 Imperial College London Company Overview
6.23.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
6.24 Indian Institute of Science Company Overview
6.24.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
6.25 Inreda Diabetic BV Company Overview
6.25.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
6.26 Joslin Diabetes Center Company Overview
6.26.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview
6.27 Kailian Medical Technology Co Ltd Company Overview
6.27.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.28 Kencak LLC Company Overview
6.28.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
6.29 McGill University Company Overview
6.29.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
6.3 Medtronic Inc Company Overview
6.30.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
6.31 Medtronic MiniMed Inc Company Overview
6.31.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview
6.32 MicroTech Medical Co Ltd Company Overview
6.32.1 MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.33 Miromatrix Medical Inc Company Overview
6.33.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.34 Modular Medical Inc Company Overview
6.34.1 Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.35 Pacific Diabetes Technologies Inc Company Overview
6.35.1 Pacific Diabetes Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.36 Pancreum, LLC Company Overview
6.36.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.37 PharmaCyte Biotech Inc Company Overview
6.37.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
6.38 Polytechnic University of Valencia Company Overview
6.38.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
6.39 Rensselaer Polytechnic Institute Company Overview
6.39.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
6.4 Senseonics Holdings Inc Company Overview
6.40.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
6.41 Shenzhen Huayuan Regenerative Medicine Co Ltd Company Overview
6.41.1 Shenzhen Huayuan Regenerative Medicine Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.42 Stanford University Company Overview
6.42.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
6.43 Tandem Diabetes Care Inc Company Overview
6.43.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
6.44 TecMed Inc Company Overview
6.44.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
6.45 TypeZero Technologies LLC Company Overview
6.45.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.46 U-Needle BV Company Overview
6.46.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
6.47 Universidad Autonoma de Madrid Company Overview
6.47.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
6.48 University of California San Francisco Company Overview
6.48.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
6.49 University of California Santa Barbara Company Overview
6.49.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
6.5 University of Cambridge Company Overview
6.50.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
6.51 University of Florida Company Overview
6.51.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
6.52 University of Minnesota Company Overview
6.52.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
6.53 University of Newcastle Company Overview
6.53.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
6.54 University of Pennsylvania Company Overview
6.54.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
6.55 University of Queensland Company Overview
6.55.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
6.56 WaveForm Technologies Inc Company Overview
6.56.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.57 Xeris Biopharma Holdings Inc Company Overview
6.57.1 Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
6.58 Yale University Company Overview
6.58.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
6.59 Ypsomed Holding AG Company Overview
6.59.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
7 Artificial Pancreas - Recent Developments
7.1 Nov 14, 2023: Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies
7.2 Nov 14, 2023: Miromatrix Reports Third Quarter 2023 Results
7.3 Oct 12, 2023: Mylife Loop Improves Health of Pregnant Women With Type 1 Diabetes and Their Babies
7.4 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
7.5 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.6 Oct 03, 2023: Insulet Announces CFO Transition
7.7 Sep 06, 2023: Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
7.8 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.9 Aug 14, 2023: Miromatrix Medical Reports Second Quarter 2023 Results and Provides Corporate Update
7.1 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.11 Jul 07, 2023: Beta Bionics Receives an Additional 510(k) Clearance for iLet Bionic Pancreas System
7.12 Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
7.13 May 22, 2023: Beta Bionics wins FDA approval for new insulin pump
7.14 May 22, 2023: Beta Bionics announces FDA clearance and commercialization of the iLet Bionic Pancreas
7.15 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.16 Apr 27, 2023: Humacyte, JDRF collaborating to develop insulin-producing Biovascular Pancreas to treat Type 1 Diabetes
7.17 Apr 12, 2023: Medtronic has a layoff in California
7.18 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.19 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
7.2 Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year
7.21 Jan 12, 2023: Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
7.22 Jan 11, 2023: Artificial pancreas successfully trialled for use by type 2 diabetes patients
7.23 Dec 07, 2022: Ypsomed and CamDiab launch the first system for automated insulin dosing with Abbott’s FreeStyle Libre 3
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Artificial Pancreas - Pipeline Products by Stage of Development
Table 2: Artificial Pancreas - Pipeline Products by Territory
Table 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Table 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Table 5: Artificial Pancreas - Ongoing Clinical Trials
Table 6: Artificial Pancreas Companies - Pipeline Products by Stage of Development
Table 7: Artificial Pancreas - Companiess Pipeline Products by Stage of Development
Table 8: Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Smart Pancreas - Product Status
Table 10: Smart Pancreas - Product Description
Table 11: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Artificial Pancreas - Product Status(Advanced Biosensors-Ohio LLC)
Table 13: Artificial Pancreas - Product Description(Advanced Biosensors-Ohio LLC)
Table 14: AiTA Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Next-Generation Artificial Pancreas - Product Status
Table 16: Next-Generation Artificial Pancreas - Product Description
Table 17: Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Gen 2 GlucoSTAT - Product Status
Table 19: Gen 2 GlucoSTAT - Product Description
Table 20: Gen 4 iLet System - Product Status
Table 21: Gen 4 iLet System - Product Description
Table 22: iLet Bionic Pancreas - Glucagon-only - Product Status
Table 23: iLet Bionic Pancreas - Glucagon-only - Product Description
Table 24: Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 25: ßAir Bio-artificial Pancreas - Product Status
Table 26: ßAir Bio-artificial Pancreas - Product Description
Table 27: Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Bigfoot Autonomy - Product Status
Table 29: Bigfoot Autonomy - Product Description
Table 30: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Artificial Pancreas - Product Status(BioTex Inc)
Table 32: Artificial Pancreas - Product Description(BioTex Inc)
Table 33: Captix Biomedical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 34: IMITA Device - Product Status
Table 35: IMITA Device - Product Description
Table 36: Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Bioartificial Pancreas - Product Status(Cerco Medical LLC)
Table 38: Bioartificial Pancreas - Product Description(Cerco Medical LLC)
Table 39: Children's Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Bihormonal Bionic Pancreas - Product Status
Table 41: Bihormonal Bionic Pancreas - Product Description
Table 42: Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Bioartificial Pancreas System - Product Status
Table 44: Bioartificial Pancreas System - Product Description
Table 45: Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Artificial Pancreas - Product Status(Covalor Medical, LLC)
Table 47: Artificial Pancreas - Product Description(Covalor Medical, LLC)
Table 48: De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
Table 49: InSmart Artificial Pancreas - Product Status
Table 50: InSmart Artificial Pancreas - Product Description
Table 51: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Next Generation Artificial Pancreas - Product Status
Table 53: Next Generation Artificial Pancreas - Product Description
Table 54: Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 55: MAILPAN - Product Status
Table 56: MAILPAN - Product Description
Table 57: Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
Table 58: DBLG1 - Adults - Product Status
Table 59: DBLG1 - Adults - Product Description
Table 60: DBLG1 - Pediatric Version - Product Status
Table 61: DBLG1 - Pediatric Version - Product Description
Table 62: Diabeloop SA - Ongoing Clinical Trials Overview
Table 63: DBLG1 - Adults - An Open-label, Multicenter, Randomized, Crossover Study, to Assess 4 Weeks Outpatient, the Clinical Efficacy of the Diabeloop Closed-loop Glucose Control without the Declaration of Meals Compared with the Diabeloop Closed-loop Glucose Control with the Declaration of Meals, in Adolescent Patients with Type 1 Diabetes Poorly Controlled
Table 64: DBLG1 - Adults - Closed-Loop Insulin Delivery in Pregnant Women with Type 1 Diabetes
Table 65: DBLG1 - Adults - Interventional Before/After Study of the Effect of the DBLG1 System with TERUMO MEDISAFE with Insulin Pump on Glucose Control of Patients With Type 1 Diabetes in France. The BETTER Trial
Table 66: DBLG1 - Adults - Observational Study of the Use of DBLG1 System in Real Life
Table 67: EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 68: EOPatchX - Product Status
Table 69: EOPatchX - Product Description
Table 70: Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: BAPIOS System - Product Status
Table 72: BAPIOS System - Product Description
Table 73: Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Pregnancy-Specific Artificial Pancreas - Product Status
Table 75: Pregnancy-Specific Artificial Pancreas - Product Description
Table 76: Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Bioengineered Pancreas - Product Status
Table 78: Bioengineered Pancreas - Product Description
Table 79: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 80: BioVascular Pancreas - Product Status
Table 81: BioVascular Pancreas - Product Description
Table 82: Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Fusion System - Product Status
Table 84: Fusion System - Product Description
Table 85: Ideal Medical Technologies Inc - Ongoing Clinical Trials Overview
Table 86: Fusion System - Demonstration of an Artificial Intelligence Based Closed Loop Glucose Control System as a Therapeutic Modality in Type 1 and Type 2 Diabetic Patients
Table 87: Fusion System - Prospective Randomized Controlled Trial For Use of the FUSION Artificial Pancreas System as a Therapy for COVID-19
Table 88: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Bio-inspired Artificial Pancreas - Product Status
Table 90: Bio-inspired Artificial Pancreas - Product Description
Table 91: Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Artificial Pancreas System - Product Status(Indian Institute of Science)
Table 93: Artificial Pancreas System - Product Description(Indian Institute of Science)
Table 94: Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Bi-Hormonal Artificial Pancreas - Lighter Version - Product Status
Table 96: Bi-Hormonal Artificial Pancreas - Lighter Version - Product Description
Table 97: Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Closed-Loop Glucagon Delivery System - Product Status
Table 99: Closed-Loop Glucagon Delivery System - Product Description
Table 100: Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Artificial Pancreas System - Product Status(Kailian Medical Technology Co Ltd)
Table 102: Artificial Pancreas System - Product Description(Kailian Medical Technology Co Ltd)
Table 103: Semi-Closed-Loop Blood Glucose Management Device - Product Status
Table 104: Semi-Closed-Loop Blood Glucose Management Device - Product Description
Table 105: Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 106: BioArtificial Pancreas - Product Status(Kencak LLC)
Table 107: BioArtificial Pancreas - Product Description(Kencak LLC)
Table 108: McGill University Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Artificial Pancreas - Type 1 Diabetes - Product Status
Table 110: Artificial Pancreas - Type 1 Diabetes - Product Description
Table 111: Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Implantable Artificial Pancreas Device - Product Status
Table 113: Implantable Artificial Pancreas Device - Product Description
Table 114: Third-Generation Artificial Pancreas System - Product Status
Table 115: Third-Generation Artificial Pancreas System - Product Description
Table 116: Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 117: Minimed 890G - Product Status
Table 118: Minimed 890G - Product Description
Table 119: MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 120: Cloud-Based AI-Powered Artificial Pancreas - Product Status
Table 121: Cloud-Based AI-Powered Artificial Pancreas - Product Description
Table 122: PanCares - Artificial Pancreas - Product Status
Table 123: PanCares - Artificial Pancreas - Product Description
Table 124: PanCares - Children And Adolescents - Product Status
Table 125: PanCares - Children And Adolescents - Product Description 6
Table 126: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 127: Miro Pancreas - Product Status
Table 128: Miro Pancreas - Product Description
Table 129: Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 130: MODD2 - Product Status
Table 131: MODD2 - Product Description
Table 132: Pacific Diabetes Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 133: SynerG - Product Status
Table 134: SynerG - Product Description
Table 135: Pacific Diabetes Technologies Inc - Ongoing Clinical Trials Overview
Table 136: SynerG - A 48hr Study to Test Feasibility of the Pacific Diabetes Technologies Continuous Glucose Monitor Infusion Set (CGMIS) Sensing Interstitial Glucose Continuously in the Immediate Vicinity of SQ Insulin Delivery in Adults With T1 Diabetes
Table 137: SynerG - Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes
Table 138: Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 139: Genesis Artificial Pancreas - Product Status
Table 140: Genesis Artificial Pancreas - Product Description
Table 141: PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 142: Bio-Artificial Pancreas - Product Status
Table 143: Bio-Artificial Pancreas - Product Description
Table 144: Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
Table 145: ClosedLoop 4Meal - Product Status
Table 146: ClosedLoop 4Meal - Product Description
Table 147: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 148: Closed-Loop Artificial Pancreas System - Product Status
Table 149: Closed-Loop Artificial Pancreas System - Product Description
Table 150: Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 6
Table 151: Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Status 6
Table 152: Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Description 6
Table 153: Shenzhen Huayuan Regenerative Medicine Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 7
Table 154: Bioartificial Pancreas - Type I Diabetes - Product Status 7
Table 155: Bioartificial Pancreas - Type I Diabetes - Product Description 7
Table 156: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 157: Artificial Pancreas Device - Product Status
Table 158: Artificial Pancreas Device - Product Description
Table 159: Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 160: t:slim X2 Control-IQ System Integrated with Dexcom G7 CGM - Product Status
Table 161: t:slim X2 Control-IQ System Integrated with Dexcom G7 CGM - Product Description
Table 162: TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 163: Artificial Pancreas - Product Status(TecMed Inc)
Table 164: Artificial Pancreas - Product Description(TecMed Inc)
Table 165: TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 166: inControl - Product Status
Table 167: inControl - Product Description
Table 168: TypeZero Technologies LLC - Ongoing Clinical Trials Overview
Table 169: inControl - Feasibility of Automated Insulin Delivery with an Interoperable Algorithm Using an Alternative Insulin Pump
Table 170: U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
Table 171: Microneedle Artificial Pancreas - Product Status
Table 172: Microneedle Artificial Pancreas - Product Description
Table 173: Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
Table 174: Predictive Rule-Based Algorithm - Product Status
Table 175: Predictive Rule-Based Algorithm - Product Description
Table 176: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
Table 177: Implantable Bioartificial Pancreas - Product Status
Table 178: Implantable Bioartificial Pancreas - Product Description
Table 179: University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 6
Table 180: Closed-Loop Artificial Pancreas - Product Status 6
Table 181: Closed-Loop Artificial Pancreas - Product Description 6
Table 182: Pediatric Artificial Pancreas - Product Status 7
Table 183: Pediatric Artificial Pancreas - Product Description 7
Table 184: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 8
Table 185: Artificial Pancreas - Type 2 Diabetes - Product Status 8
Table 186: Artificial Pancreas - Type 2 Diabetes - Product Description 8
Table 187: Florence D2A System - Product Status
Table 188: Florence D2A System - Product Description
Table 189: FlorenceM - Product Status
Table 190: FlorenceM - Product Description
Table 191: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 192: Bioartificial Pancreas - Type 1 Diabetes - Product Status
Table 193: Bioartificial Pancreas - Type 1 Diabetes - Product Description
Table 194: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 195: Implantable Microvalve Device - Product Status
Table 196: Implantable Microvalve Device - Product Description
Table 197: University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
Table 198: Closed Glucose-Sensing Insulin-Delivery System - Product Status
Table 199: Closed Glucose-Sensing Insulin-Delivery System - Product Description
Table 200: University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
Table 201: Artificial Pancreas Algorithm - Product Status
Table 202: Artificial Pancreas Algorithm - Product Description
Table 203: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
Table 204: Bionic Artificial Pancreas - Product Status
Table 205: Bionic Artificial Pancreas - Product Description
Table 206: WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 207: Closed Loop Insulin Delivery Solution - Product Status
Table 208: Closed Loop Insulin Delivery Solution - Product Description
Table 209: Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 210: Bi-Hormonal Artificial Pancreas - Product Status
Table 211: Bi-Hormonal Artificial Pancreas - Product Description
Table 212: Yale University Pipeline Products & Ongoing Clinical Trials Overview
Table 213: Automated Insulin Delivery System - Product Status
Table 214: Automated Insulin Delivery System - Product Description
Table 215: Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
Table 216: mylife Loop - Product Status
Table 217: mylife Loop - Product Description
Table 218: Glossary
2.2 List of Figures
Figure 1: Artificial Pancreas - Pipeline Products by Stage of Development
Figure 2: Artificial Pancreas - Pipeline Products by Territory
Figure 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Figure 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Figure 5: Artificial Pancreas - Ongoing Clinical Trials
"

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us